SynB1-ELP-p50i NF-κB inhibitor peptide reduces infarct volume in MCAO model
Dec. 1, 2022
Ischemic stroke comprises about 87% of stroke incidence. The nuclear factor κ B (NF-κB) cascade is a major regulatory pathway of inflammation and is activated in response to ischemic stroke in humans and in rodents during middle cerebral artery occlusion (MCAO).